Latest News & Features
Americas
California-based Sangamo Therapeutics has acquired biotech company TxCell for approximately €72 million. 25 July 2018
Americas
The Patent Trial and Appeal Board has rejected another challenge to a Gilead-owned patent covering the company’s hepatitis C medicines. 24 July 2018
Americas
The US Court of Appeals for the Federal Circuit’s ruling that tribal sovereign immunity doesn’t apply in inter partes review proceedings has sparked questions over state protections at the Patent Trial and Appeal Board. 24 July 2018
Americas
Biopharmaceutical company Kite, a subsidiary of Gilead, and immunotherapy development company Gadeta announced on Thursday, July 19 that they have entered into a strategic collaboration to produce cancer therapies. 23 July 2018
Big Pharma
The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency. 23 July 2018
Americas
Allergan and the Saint Regis Mohawk Tribe suffered a blow today as the US Court of Appeals for the Federal Circuit affirmed a decision rejecting use of tribal sovereign immunity in the inter partes review. 20 July 2018
Americas
Greenberg Traurig announced on Monday, July 16, that it has added Brian Rubenstein as a shareholder in its Philadelphia office. 20 July 2018
Biotechnology
Novartis has signed a global licensing agreement with two biotechnology companies centring on the development of an antibody treatment for inflammatory skin conditions. 20 July 2018
Americas
Sanofi has partnered with biotechnology company Revolution Medicines to develop treatments for multiple cancers. 19 July 2018
Americas
Ropes & Gray has added Charlotte Jacobsen from Fitzpatrick, Cella, Harper & Scinto as a partner in the firm’s life sciences IP litigation practice. 19 July 2018